These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Chemical biology and drug design: three-dimensional, dynamic, and mechanistic nature of two multidisciplinary fields. Sawyer TK Chem Biol Drug Des; 2006 Mar; 67(3):196-200. PubMed ID: 16611212 [No Abstract] [Full Text] [Related]
26. Nanomagnetosols: magnetism opens up new perspectives for targeted aerosol delivery to the lung. Plank C Trends Biotechnol; 2008 Feb; 26(2):59-63. PubMed ID: 18191261 [TBL] [Abstract][Full Text] [Related]
27. Studies on the intracellular release of genetic drugs from pharmaceutical carriers. Lucas B; Remaut K; De Smedt SC; Demeester J J Control Release; 2005 Jan; 101(1-3):402-5. PubMed ID: 15822237 [No Abstract] [Full Text] [Related]
30. Targeted drug delivery to the brain using focused ultrasound. Kinoshita M Top Magn Reson Imaging; 2006 Jun; 17(3):209-15. PubMed ID: 17414078 [TBL] [Abstract][Full Text] [Related]
31. Using computational modeling to drive the development of targeted therapeutics. Nielsen UB; Schoeberl B IDrugs; 2005 Oct; 8(10):822-6. PubMed ID: 16254802 [TBL] [Abstract][Full Text] [Related]
32. Are stimulators of fat oxidation interesting drug discovery targets? Levens N Curr Opin Investig Drugs; 2005 Apr; 6(4):363. PubMed ID: 15898341 [No Abstract] [Full Text] [Related]
33. Delivery systems to increase the selectivity of antibiotics in phagocytic cells. Briones E; Colino CI; Lanao JM J Control Release; 2008 Feb; 125(3):210-27. PubMed ID: 18077047 [TBL] [Abstract][Full Text] [Related]
35. [Targeted therapy for primary hepatocellular carcinoma]. Ye SL Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):322-3. PubMed ID: 15918961 [No Abstract] [Full Text] [Related]
36. Multiparticulate formulation approach to pulsatile drug delivery: current perspectives. Roy P; Shahiwala A J Control Release; 2009 Mar; 134(2):74-80. PubMed ID: 19105973 [TBL] [Abstract][Full Text] [Related]
37. Advances in cancer therapy: targeted agents. Gaguski ME; Begyn P Nurs Manage; 2008 May; 39(5):45-8. PubMed ID: 18460908 [No Abstract] [Full Text] [Related]
38. Microfabricated nanochannel implantable drug delivery devices: trends, limitations and possibilities. Gardner P Expert Opin Drug Deliv; 2006 Jul; 3(4):479-87. PubMed ID: 16822223 [TBL] [Abstract][Full Text] [Related]
39. Novel delivery of oligonucleotides using a topical hydrogel tissue sealant in a murine partial nephrectomy model. Ramakumar S; Phull H; Purves T; Funk J; Copeland D; Ulreich JB; Lai LW; Lien YH J Urol; 2005 Sep; 174(3):1133-6. PubMed ID: 16094080 [TBL] [Abstract][Full Text] [Related]
40. Advances and challenges of nanotechnology-based drug delivery systems. Jiang W; Kim BY; Rutka JT; Chan WC Expert Opin Drug Deliv; 2007 Nov; 4(6):621-33. PubMed ID: 17970665 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]